Amco Biopharm Technology Corp is categorized under Business Services (Unclassified) in Schenectady, NY and active since 2001.
Amco Biopharm Technology Corp was established in 2001, and today employs 1 to 4, earning $50.000 to $99.999 per year. This is a Business Services (Unclassified) business, which does work in the B2B market, and is classified as a Business Services (Unclassified), under code number 561499 by the NAICS.
If you are seeking more information, feel free to contact T Su at the company’s single location by writing to 2259 Berkley Avenue, Schenectady, New York NY 12309 or by phoning (518) 370-3528. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Amco Biopharm Technology Corp |
| Contact Person: | T Su |
| Address: | 2259 Berkley Avenue, Schenectady, New York 12309 |
| Phone Number: | (518) 370-3528 |
| Annual Revenue (USD): | $50.000 to $99.999 |
| Founded: | 2001 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Business Services (Unclassified) |
| SIC Code: | 7389 |
| NAICS Code: | 561499 |
| Share This Business: |
Amco Biopharm Technology Corp was started in 2001 to provide professional Business Services (Unclassified) under the SIC code 7389 and NAICS code 561499. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000 to $99.999 per annum.
Feel free to contact T Su for inquiries that concern Amco Biopharm Technology Corp by calling the company number (518) 370-3528, as your correspondence is most welcome. Additionally, the physical location of the single location of Amco Biopharm Technology Corp can be found at the coordinates as well as the street address 2259 Berkley Avenue in Schenectady, New York 12309.
For its online presence, you may visit Amco Biopharm Technology Corp’s website at and engage with its social media outlets through on Twitter and on Facebook.